Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    9024663 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia

Study has passed its completion date and status has not been verified in more than two years.